Natural history of intermittent claudication;Evolución natural de la claudicación intermitente

Angiologia

Volumn 55, Issue SUPPL. 1, 2003, Pages

  Blanes Mompó, José Ignacio ^a   Plaza Martinez A ^a   Zaragoza Garcia J M ^a   Gallego Torrome, L M ^a   Ortiz Monzon E ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Cardiovascular morbidity and mortality; Intermittent claudication; Natural history; Superficial femoral artery

Indexed keywords

ACCURACY; ANKLE BRACHIAL ARTERY PRESSURE; ANKLE PRESSURE; ATHEROMA; CONFERENCE PAPER; DISEASE COURSE; HUMAN; INTERMITTENT CLAUDICATION; MORBIDITY; MORTALITY; PATHOGENESIS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT;

EID: 0041928211     PISSN: 00033170     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (71)

1. Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodelling. Mechanisms and clinical implications. Circulation 2000; 102: 1186-91.
2. Glagov S, Weisenberg E, Zains CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371-5.
3. Pasterkamp G, Wensing PJ, Post MJ, Hillen B, Mali WP, Borst C. Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. Circulation 1995; 91: 1444-9.
4. Vink A, Schoneveld AH, Borst C, Pasterkamp G. The contribution of plaque and arterial remodelling to de novo atherosclerotic luminal narrowing in the femoral artery. J Vasc Surg. 2002; 36: 1194-8.
5. TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease. J Vasc Surg 2000; 31: 5-34.
6. Walsh DB, Gilbertson JJ, Zwolak RM, Besso S, Edelman GC, Schneider JR, et al. The natural history of superficial femoral artery stenosis. J Vasc Surg 1991; 14: 299-304.
7. Walsh DB, Powel RI, Stukel TA, Henderson EL, Cronenwett JL. Superficial femoral artery stenoses: characteristics of progressing lesions. J Vasc Surg 1997; 25: 512-21.
8. Whyman MR, Ruckley CV, Fowkes FGR. A prospective study of the natural history of femoropopliteal artery stenosis using duplex ultrasound. Eur J Vasc Surg 1993; 7: 444-7.
9. Mavor GE. The pattern of occlusion in atheroma of the lower limb arteries. Br J Surg 1952; 40: 352-64.
10. Blair JM, Glagov S, Zarins CK. Mechanism of superficial femoral artery adductor canal stenosis. Surg Forum 1990; 41: 359-60.
11. Falk E. Why do plaques rupture? Circulation 1992; 86: 30-42.
12. Fuster V, Badimon JJ, Badimon L. Clinical-pathological correlations of coronary disease progression and regression. Circulation 1992; 86: 1-11.
13. Cronenwett JL, Warner KG, Zelenock GB, Whitehouse WM Jr, Graham LM, Lindenauer SM, et al. Intermittent claudication: current results of nonoperative management. Arch Surg 1984; 119: 430-6.
14. Mecley M, Rosenfield K, Kaufman J, Langevin RE Jr, Razvi S, Isner JM. Atherosclerotic plaque hemorrhage and rupture associated with crescendo claudication. Ann Intern Med 1992; 117: 663-6.
15. Coran AG, Warren R. Arteriographic changes in femoropopliteal arteriosclerosis obliterans. N Engl J Med 1966; 274: 643-7.
16. Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg 1999; 12: 123-37.
17. Imparato AM, Davidson T, Crowley JG. Intermittent claudication: its natural course. Surgery 1975; 78: 795-9.
18. Allister MC. The fate of patients with intermittent claudication managed nonoperatively. Am J Surg 1976; 132: 875-83.
19. O'Riordain DS, O'Donnell JA. Realistic expectations for the patient with intermittent claudication. Br J Surg 1991; 78: 861-3.
20. Brevetti G, Martone VD, Peina S, Cacciatore F, Corrado S, Di Donato A, et al. Intermittent claudication and risk of cardiovascular events. Angiology 1998; 49: 843-8.
21. Dormandy J, Murray GD. The fate of claudicant: a prospective study of 1969 claudicants. Eur J Vasc Surg 1991; 5: 131-3.
22. Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dunbar J, Housley E, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172-81.
23. Jonason T, Ringqvist I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand 1985; 218: 27-33.
24. Rosenbloom MS, Flaningam DP, Schler JJ. Risk factors affecting the natural history of intermittent claudication. Arch Surg 1988; 123: 867-9.
25. Bloor K. Natural history of atherosclerosis of the lower extremities. Ann Coll Surg 1996; 28: 36-51.
26. Hale WE, Marks RG, May FE, Moore MT, Stewart RB. Epidemiology of intermittent claudication: evaluation of risk factors. Age Ageing 1988; 17: 57-60.
27. McGill HC. Persistent problems in the pathogenesis of atherosclerosis. Arteriosclerosis 1984; 4: 443-51.
28. Muluk SC, Muluk VS, Kelley ME, Whittle JC, Tierney JA, Webster MW, et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg 2001; 33: 251-7.
29. Schildkraut JM, Myers RH, Cupples LA, Kiely DK, Kannel WB. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am J Cardiol 1989; 64: 555-9.
30. Jelnes R, Gaardsting O, Hougaard-Jensen K, Baekgaard N, Tonnesen KH, Schroeder T. Fate in intermittent claudication: outcome and risk factors. Br Med J 1986; 293: 1137-40.
31. McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 1989; 3: 273-7.
32. Naschitz JE, Ambrosio DA, Chang JB. Intermittent claudication: predictors and outcome. Angiology 1988; 39: 16-22.
33. Bowers BL, Valentine RJ, Myers SI, Chervu A, Clagett GP. The natural history of patients with claudication with toe pressures of 40 mmHg or less. J Vasc Surg 1993; 18: 506-11.
34. Fowl RJ, Gewirtz RJ, Love MC, Kempczinski RF. Natural history of claudicants with critical hemodynamic indices. Ann Vasc Surg 1992; 6: 31-3.
35. Kannel WB, Skinner JJ, Schwartz MJ. Intermittent claudication incidence in Framingham study. Circulation 1970; 41: 875-83.
36. Dormandy J, Belcher G, Broos P, Eikelboom B, Laszlo G, Konrad P, et al. Prospective study of 713 below-knee amputations for ischaemia and the effect of a prostacyclin analogue on healing. Hawaii Study Group. Br J Surg 1994; 81: 33-7.
37. Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994; 1: 333-9.
38. Jonason T, Ringqvist I. Changes in peripheral blood pressures after five years of follow up in non-operated patients with intermittent claudication. Acta Med Scand 1986; 220: 127-32.
39. Hughson WG, Jun JI, Garrod A. Intermittent claudication: Prevalence and risk factors. Br Med J; 1978; 1: 1379-81.
40. Taylor MS, Calo MR. Atherosclerosis of arteries of lower limbs. Br Med J 1962; 24: 507-19.
41. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication: A risk profile from the Framingham Heart Study. Circulation 1997; 96: 44-9.
42. Beeg TB, Richards RL. The prognosis of intermittent claudication. Scott Med J 1962; 7: 342-52.
43. De Weese JA, Rob CG. Autogenous vein graft ten years later. Surgery 1962; 6: 775-84.
44. Malone JM, Moore WS, Goldstone J. Life expectancy following aortofemoral arterial grafting. Surgery 1977; 81: 551-5.
45. Szilagyi DE, Hageman JH, Smith RF. Autogenous vein grafting in femoropopliteal atherosclerosis: The limits of its effectiveness. Surgery 1979; 86: 836-51.
46. Crawford ES, Bomberger RA, Glaeser DH. Aortoiliac occlusive disease: Factors influencing survival and function following reconstructive operation over twenty-five years period. Surgery 1981; 90: 1055-67.
47. Hertzer NR. Fatal myocardial infarction following lower extremity revascularization: two hundred and seventy-three patients followed six to eleven postoperative years. Ann Surg 1981; 193: 492-8.
48. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease and atherothrombotic brain infarction in men and women = 62 years of age. Am J Cardiol 1994; 74: 64-5.
49. Von Kemp K, van den Brande P, Peterson P. Screening for concomitant diseases in peripheral vascular patients. Int Angiol 1997; 16: 114-22.
50. Vecht RJ, Nicolaides AN, Brandao E. Resting and treadmill electrocardiographic findings in patients with intermittent claudication. Int Angiol 1982; 1: 119-21.
51. Brewster DC, Okada RD, Strauss HW. Selection of patients for preoperative coronary angiography: Use of dipyridamole stress-thallium myocardial imaging. J Vasc Surg 1985; 2: 504-10.
52. Hertzer NR, Beven EG, Young JR. Coronary artery disease in peripheral vascular patients: A classification of 1000 coronary angiograms and results of surgIcal management. Ann Surg 1984; 199: 223-33.
53. Bhardwaj R, Ganju N, Sharma M, Sud S, Asotra S. Prevalence of coronary artery disease in patients with symptomatic peripheral vascular disease. Indian Heart J 2001; 53: 189-91.
54. Fowkes FGR, Housley E, Cawood EHH. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-92.
55. Hertzer NR. The natural history of peripheral vascular disease: Implications for its management. Circulation 1991; 83: 12-9.
56. Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effects on mortality. Acta Med Scand 1982; 211: 249-56.
57. Kafetzakis A, Giannoukas AD, Kochiadakis G, Igoumenidis N, Vlachonikolis IG, Tsetis D, et al. Occult aorto-iliac disease in patients with symptomatic coronary artery disease. Int Angiol 2001; 20: 295-300.
58. Tellier P, Aquilanti S, Lacouffe P, Vasseur C. Comparison between exercise whole body thallium imaging and ankle-brachial index in the detection of peripheral arterial disease. Int Angiol 2000; 19: 212-9.
59. Atmer B, Jogestrand T, Laska J. Peripheral artery disease in patients with coronary arterial disease. Int Angiol 1995; 14: 89-93.
60. Tsai AW, Folsom AR, Rosamond WD, Jones DW. Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke 2001; 32: 1721-4.
61. Turnipseed WD, Berkoff HA, Belzer FO. Postoperative stroke in cardiac and peripheral vascular disease. Ann Surg 1980; 192: 365-8.
62. Hennerici M, Aulich A, Sandeman W, Freund HJ. Incidente of asymptomatic extracranial arterial disease. Stroke 1981; 12: 750-8.
63. Klop RB, Eikelboom BC, Taks AC. Screening of the internal carotid arteries in patients with peripheral vascular disease by colour-flow Duplex scanning. Eur J Vasc Surg 1991; 5: 41-5.
64. Alexandrova NA, Gibson WC, Norris JW, Maggisano R. Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 1996; 23: 645-9.
65. Newman AB, Siscovick DJ, Manolio TA. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993; 88: 837-45.
66. Bots ML, Hofman A, Grobee DE. Common carotid intimal media thickness and lower extremity atherosclerosis. The Rotterdam Study. Atheroscler Thromb 1994; 14:1885-91.
67. Allan PL, Mowbray PI, Lee AJ. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. Stroke 1997; 28: 348-53.
68. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 1996; 348: 1329-39.
69. Dormandy J, Heeck L, Vig S. Lower-extremity arteriosclerosis as a reflection of a systemic process: implications for concomitant coronary and carotid disease. Sem Vasc Surg 1999; 12: 118-22.
70. Kallero KS, Bergqvist D, Cederholm C. Late mortality and morbidity after arterial reconstruction: The influence of arteriosclerosis in popliteal artery trifurcation. J Vasc Surg 1985; 2: 541-6.
71. Kobayashi M, Shindo S, Kubota K, Kojima A, Ishimoto T, Iyori K. Causes of late mortality in patients with disabling intermittent claudication. Jpn Circ J 2000; 64: 925-7.